25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

41L (Laboratorios Farmaceuticos Rovi S.A) Stock Analysis
Buy, Hold or Sell?

Let's analyze Laboratorios Farmaceuticos Rovi S.A together

I guess you are interested in Laboratorios Farmaceuticos Rovi S.A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Laboratorios Farmaceuticos Rovi S.A’s Financial Insights
  • 📈 Technical Analysis (TA) – Laboratorios Farmaceuticos Rovi S.A’s Price Targets

I'm going to help you getting a better view of Laboratorios Farmaceuticos Rovi S.A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Laboratorios Farmaceuticos Rovi S.A

I send you an email if I find something interesting about Laboratorios Farmaceuticos Rovi S.A.

1. Quick Overview

1.1. Quick analysis of Laboratorios Farmaceuticos Rovi S.A (30 sec.)










1.2. What can you expect buying and holding a share of Laboratorios Farmaceuticos Rovi S.A? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
31.3%

What is your share worth?

Current worth
€11.24
Expected worth in 1 year
€13.03
How sure are you?
68.8%

+ What do you gain per year?

Total Gains per Share
€1.80
Return On Investment
3.0%

For what price can you sell your share?

Current Price per Share
€59.90
Expected price per share
€50.64 - €69.87
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Laboratorios Farmaceuticos Rovi S.A (5 min.)




Live pricePrice per Share (EOD)
€59.90
Intrinsic Value Per Share
€-45.15 - €-54.88
Total Value Per Share
€-33.91 - €-43.64

2.2. Growth of Laboratorios Farmaceuticos Rovi S.A (5 min.)




Is Laboratorios Farmaceuticos Rovi S.A growing?

Current yearPrevious yearGrowGrow %
How rich?$676.2m$619m$61.5m9.0%

How much money is Laboratorios Farmaceuticos Rovi S.A making?

Current yearPrevious yearGrowGrow %
Making money$59.2m$58.8m$354.1k0.6%
Net Profit Margin19.0%18.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Laboratorios Farmaceuticos Rovi S.A (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Laboratorios Farmaceuticos Rovi S.A?

Welcome investor! Laboratorios Farmaceuticos Rovi S.A's management wants to use your money to grow the business. In return you get a share of Laboratorios Farmaceuticos Rovi S.A.

First you should know what it really means to hold a share of Laboratorios Farmaceuticos Rovi S.A. And how you can make/lose money.

Speculation

The Price per Share of Laboratorios Farmaceuticos Rovi S.A is €59.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Laboratorios Farmaceuticos Rovi S.A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Laboratorios Farmaceuticos Rovi S.A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €11.24. Based on the TTM, the Book Value Change Per Share is €0.45 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Laboratorios Farmaceuticos Rovi S.A.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.500.8%1.161.9%1.131.9%1.182.0%1.131.9%1.131.9%
Usd Book Value Change Per Share-0.57-1.0%0.530.9%-0.09-0.1%0.370.6%0.831.4%0.831.4%
Usd Dividend Per Share0.000.0%0.000.0%0.380.6%0.510.9%0.390.6%0.390.6%
Usd Total Gains Per Share-0.57-1.0%0.530.9%0.290.5%0.881.5%1.212.0%1.212.0%
Usd Price Per Share64.60-70.51-82.10-66.48-68.54-68.54-
Price to Earnings Ratio32.45-22.66-31.85-21.49-21.12-21.12-
Price-to-Total Gains Ratio-113.23-54.06-517.35-216.51-154.78-154.78-
Price to Book Ratio4.89-5.32-6.94-5.45-6.07-6.07-
Price-to-Total Gains Ratio-113.23-54.06-517.35-216.51-154.78-154.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share70.47834
Number of shares14
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.39
Usd Book Value Change Per Share0.530.83
Usd Total Gains Per Share0.531.21
Gains per Quarter (14 shares)7.4016.96
Gains per Year (14 shares)29.6167.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103020224658
2059504393126
30898065139194
4011811086185262
50148140108231330
60178170129278398
70207200151324466
80237230173370534
90267260194416602
100296290216463670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%16.00.00.0100.0%16.00.00.0100.0%16.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%10.06.00.062.5%10.06.00.062.5%10.06.00.062.5%
Dividend per Share0.00.04.00.0%4.00.08.033.3%5.00.011.031.3%5.00.011.031.3%5.00.011.031.3%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%11.05.00.068.8%11.05.00.068.8%11.05.00.068.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Laboratorios Farmaceuticos Rovi S.A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.4850.449-208%-0.075-84%0.311-256%0.702-169%0.702-169%
Book Value Per Share--11.23611.310-1%10.150+11%10.419+8%9.817+14%9.817+14%
Current Ratio--2.7683.025-8%2.410+15%2.535+9%2.496+11%2.496+11%
Debt To Asset Ratio--0.3390.317+7%0.354-4%0.358-5%0.370-8%0.370-8%
Debt To Equity Ratio--0.5230.477+10%0.563-7%0.574-9%0.605-14%0.605-14%
Dividend Per Share----0%0.326-100%0.436-100%0.327-100%0.327-100%
Enterprise Value--2513217440.2002795264195.650-10%3315202469.525-24%2616143795.510-4%2754185042.989-9%2754185042.989-9%
Eps--0.4230.984-57%0.963-56%1.004-58%0.962-56%0.962-56%
Ev To Sales Ratio--3.9343.269+20%4.143-5%3.192+23%3.465+14%3.465+14%
Free Cash Flow Per Share---0.0660.353-119%0.169-139%0.270-124%0.423-116%0.423-116%
Free Cash Flow To Equity Per Share---0.0660.353-119%-0.249+277%-0.151+129%0.107-162%0.107-162%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---54.878----------
Intrinsic Value_10Y_min---45.150----------
Intrinsic Value_1Y_max--0.129----------
Intrinsic Value_1Y_min--0.130----------
Intrinsic Value_3Y_max---3.901----------
Intrinsic Value_3Y_min---3.638----------
Intrinsic Value_5Y_max---13.103----------
Intrinsic Value_5Y_min---11.792----------
Market Cap--2808107440.2003065145945.650-8%3605682719.525-22%2918177128.843-4%3055966855.489-8%3055966855.489-8%
Net Profit Margin--0.1350.190-29%0.185-27%0.198-31%0.210-35%0.210-35%
Operating Margin----0%0.080-100%0.060-100%0.045-100%0.045-100%
Operating Ratio--1.1661.106+5%1.152+1%1.121+4%1.111+5%1.111+5%
Pb Ratio5.331+8%4.8865.317-8%6.939-30%5.453-10%6.072-20%6.072-20%
Pe Ratio35.404+8%32.44922.661+43%31.855+2%21.486+51%21.123+54%21.123+54%
Price Per Share59.900+8%54.90059.925-8%69.775-21%56.500-3%58.256-6%58.256-6%
Price To Free Cash Flow Ratio-226.416-9%-207.516-20.543-90%88.097-336%23.304-990%11.779-1862%11.779-1862%
Price To Total Gains Ratio-123.543-9%-113.23154.063-309%517.348-122%216.511-152%154.779-173%154.779-173%
Quick Ratio--0.7390.831-11%0.634+17%0.674+10%0.668+11%0.668+11%
Return On Assets--0.0250.059-58%0.061-60%0.058-57%0.059-58%0.059-58%
Return On Equity--0.0380.089-57%0.094-59%0.091-58%0.095-59%0.095-59%
Total Gains Per Share---0.4850.449-208%0.250-294%0.747-165%1.030-147%1.030-147%
Usd Book Value--676209669.000680636920.650-1%619090445.400+9%634563029.550+7%604617088.800+12%604617088.800+12%
Usd Book Value Change Per Share---0.5700.529-208%-0.089-84%0.366-256%0.826-169%0.826-169%
Usd Book Value Per Share--13.22013.307-1%11.943+11%12.259+8%11.550+14%11.550+14%
Usd Dividend Per Share----0%0.383-100%0.513-100%0.385-100%0.385-100%
Usd Enterprise Value--2957051640.1393288907852.602-10%3900667225.643-24%3078154789.797-4%3240574121.581-9%3240574121.581-9%
Usd Eps--0.4981.158-57%1.133-56%1.182-58%1.132-56%1.132-56%
Usd Free Cash Flow---3980437.80021227923.050-119%10227595.500-139%16470144.850-124%26479677.150-115%26479677.150-115%
Usd Free Cash Flow Per Share---0.0780.415-119%0.199-139%0.318-124%0.498-116%0.498-116%
Usd Free Cash Flow To Equity Per Share---0.0780.415-119%-0.293+277%-0.178+129%0.126-162%0.126-162%
Usd Market Cap--3304019214.1393606450719.652-8%4242446287.793-22%3433527209.797-4%3595650602.168-8%3595650602.168-8%
Usd Price Per Share70.478+8%64.59570.508-8%82.097-21%66.478-3%68.544-6%68.544-6%
Usd Profit--25455741.00059247398.850-57%58893242.250-57%57587608.450-56%56624095.613-55%56624095.613-55%
Usd Revenue--187900666.800289525667.850-35%291805036.200-36%273995920.550-31%259843064.888-28%259843064.888-28%
Usd Total Gains Per Share---0.5700.529-208%0.295-294%0.879-165%1.211-147%1.211-147%
 EOD+2 -4MRQTTM+4 -31YOY+12 -263Y+13 -255Y+11 -2710Y+11 -27

3.3 Fundamental Score

Let's check the fundamental score of Laboratorios Farmaceuticos Rovi S.A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1535.404
Price to Book Ratio (EOD)Between0-15.331
Net Profit Margin (MRQ)Greater than00.135
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.739
Current Ratio (MRQ)Greater than12.768
Debt to Asset Ratio (MRQ)Less than10.339
Debt to Equity Ratio (MRQ)Less than10.523
Return on Equity (MRQ)Greater than0.150.038
Return on Assets (MRQ)Greater than0.050.025
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Laboratorios Farmaceuticos Rovi S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose59.700
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Laboratorios Farmaceuticos Rovi S.A

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Laboratorios Farmaceuticos Rovi S.A earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • A Net Profit Margin of 13.5% means that €0.14 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 13.5%. The company is making a huge profit. +2
  • The TTM is 19.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.5%TTM19.0%-5.4%
TTM19.0%YOY18.5%+0.5%
TTM19.0%5Y21.0%-2.0%
5Y21.0%10Y21.0%0.0%
4.3.1.2. Return on Assets

Shows how efficient Laboratorios Farmaceuticos Rovi S.A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • 2.5% Return on Assets means that Laboratorios Farmaceuticos Rovi S.A generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 2.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 5.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ2.5%TTM5.9%-3.4%
TTM5.9%YOY6.1%-0.2%
TTM5.9%5Y5.9%0.0%
5Y5.9%10Y5.9%0.0%
4.3.1.3. Return on Equity

Shows how efficient Laboratorios Farmaceuticos Rovi S.A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • 3.8% Return on Equity means Laboratorios Farmaceuticos Rovi S.A generated €0.04 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 3.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 8.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.8%TTM8.9%-5.1%
TTM8.9%YOY9.4%-0.5%
TTM8.9%5Y9.5%-0.5%
5Y9.5%10Y9.5%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Laboratorios Farmaceuticos Rovi S.A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Laboratorios Farmaceuticos Rovi S.A is operating .

  • Measures how much profit Laboratorios Farmaceuticos Rovi S.A makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY8.0%-8.0%
TTM-5Y4.5%-4.5%
5Y4.5%10Y4.5%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Laboratorios Farmaceuticos Rovi S.A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are €1.17 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 1.166. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.106. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.166TTM1.106+0.061
TTM1.106YOY1.152-0.046
TTM1.1065Y1.111-0.005
5Y1.11110Y1.1110.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Laboratorios Farmaceuticos Rovi S.A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Laboratorios Farmaceuticos Rovi S.A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 2.77 means the company has €2.77 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 2.768. The company is able to pay all its short-term debts. +1
  • The TTM is 3.025. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.768TTM3.025-0.257
TTM3.025YOY2.410+0.615
TTM3.0255Y2.496+0.529
5Y2.49610Y2.4960.000
4.4.3.2. Quick Ratio

Measures if Laboratorios Farmaceuticos Rovi S.A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • A Quick Ratio of 0.74 means the company can pay off €0.74 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 0.739. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.831. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.739TTM0.831-0.092
TTM0.831YOY0.634+0.197
TTM0.8315Y0.668+0.164
5Y0.66810Y0.6680.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Laboratorios Farmaceuticos Rovi S.A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Laboratorios Farmaceuticos Rovi S.A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to industry mean.
  • A Debt to Asset Ratio of 0.34 means that Laboratorios Farmaceuticos Rovi S.A assets are financed with 33.9% credit (debt) and the remaining percentage (100% - 33.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 0.339. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.317. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.339TTM0.317+0.022
TTM0.317YOY0.354-0.037
TTM0.3175Y0.370-0.053
5Y0.37010Y0.3700.000
4.5.4.2. Debt to Equity Ratio

Measures if Laboratorios Farmaceuticos Rovi S.A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • A Debt to Equity ratio of 52.3% means that company has €0.52 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 0.523. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.477. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.523TTM0.477+0.046
TTM0.477YOY0.563-0.086
TTM0.4775Y0.605-0.128
5Y0.60510Y0.6050.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Laboratorios Farmaceuticos Rovi S.A generates.

  • Above 15 is considered overpriced but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • A PE ratio of 32.45 means the investor is paying €32.45 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The EOD is 35.404. Based on the earnings, the company is overpriced. -1
  • The MRQ is 32.449. Based on the earnings, the company is overpriced. -1
  • The TTM is 22.661. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD35.404MRQ32.449+2.955
MRQ32.449TTM22.661+9.788
TTM22.661YOY31.855-9.194
TTM22.6615Y21.123+1.538
5Y21.12310Y21.1230.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The EOD is -226.416. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -207.516. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -20.543. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-226.416MRQ-207.516-18.899
MRQ-207.516TTM-20.543-186.973
TTM-20.543YOY88.097-108.640
TTM-20.5435Y11.779-32.323
5Y11.77910Y11.7790.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Laboratorios Farmaceuticos Rovi S.A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 4.89 means the investor is paying €4.89 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The EOD is 5.331. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.886. Based on the equity, the company is fair priced.
  • The TTM is 5.317. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.331MRQ4.886+0.445
MRQ4.886TTM5.317-0.431
TTM5.317YOY6.939-1.621
TTM5.3175Y6.072-0.755
5Y6.07210Y6.0720.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets869,605
Total Liabilities294,890
Total Stockholder Equity563,634
 As reported
Total Liabilities 294,890
Total Stockholder Equity+ 563,634
Total Assets = 869,605

Assets

Total Assets869,605
Total Current Assets516,305
Long-term Assets353,300
Total Current Assets
Cash And Cash Equivalents 46,114
Short-term Investments 1,507
Net Receivables 136,281
Inventory 327,669
Total Current Assets  (as reported)516,305
Total Current Assets  (calculated)511,571
+/- 4,734
Long-term Assets
Property Plant Equipment 294,247
Goodwill 2,702
Intangible Assets 33,021
Long-term Assets  (as reported)353,300
Long-term Assets  (calculated)329,970
+/- 23,330

Liabilities & Shareholders' Equity

Total Current Liabilities186,513
Long-term Liabilities108,377
Total Stockholder Equity563,634
Total Current Liabilities
Accounts payable 64,596
Total Current Liabilities  (as reported)186,513
Total Current Liabilities  (calculated)64,596
+/- 121,917
Long-term Liabilities
Long-term Liabilities  (as reported)108,377
Long-term Liabilities  (calculated)0
+/- 108,377
Total Stockholder Equity
Retained Earnings 476,905
Total Stockholder Equity (as reported)563,634
Total Stockholder Equity (calculated)476,905
+/- 86,729
Other
Capital Stock3,074
Common Stock Shares Outstanding 51,149
Net Invested Capital 563,634
Net Working Capital 329,792
Property Plant and Equipment Gross 546,753



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302019-06-302019-03-312018-12-312018-09-30
> Total Assets 
0
0
0
0
685,066
732,676
744,859
791,565
772,466
878,703
885,195
899,832
830,725
799,884
778,663
857,325
877,848
832,022
813,963
869,605
869,605813,963832,022877,848857,325778,663799,884830,725899,832885,195878,703772,466791,565744,859732,676685,0660000
   > Total Current Assets 
183,881
254,004
245,528
266,864
476,502
506,362
521,958
566,934
543,620
623,073
631,586
637,965
567,063
509,331
485,415
540,781
553,829
489,606
467,855
516,305
516,305467,855489,606553,829540,781485,415509,331567,063637,965631,586623,073543,620566,934521,958506,362476,502266,864245,528254,004183,881
       Cash And Cash Equivalents 
0
0
0
0
143,961
99,035
101,736
157,627
97,639
124,945
141,462
153,812
56,377
25,322
13,085
44,578
17,554
27,186
29,306
46,114
46,11429,30627,18617,55444,57813,08525,32256,377153,812141,462124,94597,639157,627101,73699,035143,9610000
       Short-term Investments 
0
0
0
0
0
0
0
1,225
0
0
0
1,606
0
0
0
0
0
227
0
1,507
1,5070227000001,6060001,2250000000
       Net Receivables 
62,343
62,200
65,884
76,929
109,590
150,172
169,159
140,157
150,182
181,281
160,398
126,379
139,133
143,314
131,488
136,603
185,509
129,471
116,244
136,281
136,281116,244129,471185,509136,603131,488143,314139,133126,379160,398181,281150,182140,157169,159150,172109,59076,92965,88462,20062,343
       Inventory 
102,555
94,861
108,309
121,734
220,769
245,473
247,154
265,144
291,932
311,944
327,058
351,400
365,679
337,968
337,971
355,486
346,662
329,954
319,412
327,669
327,669319,412329,954346,662355,486337,971337,968365,679351,400327,058311,944291,932265,144247,154245,473220,769121,734108,30994,861102,555
   > Long-term Assets 
0
0
0
0
208,564
226,314
222,901
224,631
228,846
255,630
253,609
261,867
263,662
290,553
293,248
316,544
324,019
342,416
346,108
353,300
353,300346,108342,416324,019316,544293,248290,553263,662261,867253,609255,630228,846224,631222,901226,314208,5640000
       Property Plant Equipment 
90,592
95,837
117,283
121,064
0
0
0
0
187,474
215,541
215,463
223,785
226,655
253,652
256,616
261,214
269,597
286,622
288,189
294,247
294,247288,189286,622269,597261,214256,616253,652226,655223,785215,463215,541187,4740000121,064117,28395,83790,592
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,702
2,7020000000000000000000
       Intangible Assets 
0
0
0
0
0
38,558
0
36,901
0
35,744
0
34,249
0
33,902
0
33,032
0
33,950
0
33,021
33,021033,950033,032033,902034,249035,744036,901038,55800000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65
0
0
006500000000000000000
> Total Liabilities 
0
0
0
0
232,034
261,700
319,160
391,215
329,182
357,324
316,399
380,047
276,087
256,390
254,881
374,563
319,660
250,482
214,495
294,890
294,890214,495250,482319,660374,563254,881256,390276,087380,047316,399357,324329,182391,215319,160261,700232,0340000
   > Total Current Liabilities 
85,839
87,512
89,398
104,913
159,434
190,388
248,705
320,569
258,337
293,887
255,405
321,594
220,774
199,843
191,246
272,455
221,489
156,651
126,277
186,513
186,513126,277156,651221,489272,455191,246199,843220,774321,594255,405293,887258,337320,569248,705190,388159,434104,91389,39887,51285,839
       Short Long Term Debt 
0
0
0
0
0
2,959
0
2,788
0
8,238
0
0
0
8,060
0
0
0
17,842
0
0
0017,8420008,0600008,23802,78802,95900000
       Accounts payable 
63,413
49,512
70,125
68,501
101,430
97,407
133,376
97,564
126,237
130,455
135,331
107,934
113,637
107,593
106,639
80,876
124,270
86,851
90,839
64,596
64,59690,83986,851124,27080,876106,639107,593113,637107,934135,331130,455126,23797,564133,37697,407101,43068,50170,12549,51263,413
       Other Current Liabilities 
3,548
8,989
1,820
15,452
0
0
0
0
0
116,359
0
0
95,557
0
0
0
0
5,248
0
0
005,248000095,55700116,3590000015,4521,8208,9893,548
   > Long-term Liabilities 
0
0
0
0
72,600
71,312
70,455
70,646
70,845
63,437
60,994
58,453
55,313
56,547
63,635
102,108
98,171
93,831
88,218
108,377
108,37788,21893,83198,171102,10863,63556,54755,31358,45360,99463,43770,84570,64670,45571,31272,6000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
17,663
0
17,568
0
17,856
0
0
0
18,792
0
0
0
16,065
0
0
0016,06500018,79200017,856017,568017,66300000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,746
0
0
002,74600000000000000000
       Deferred Long Term Liability 
0
8,371
0
8,150
0
0
0
0
0
6,603
0
0
0
0
0
0
0
0
0
0
00000000006,603000008,15008,3710
> Total Stockholder Equity
0
0
0
0
453,032
470,976
425,553
399,022
441,921
520,012
567,259
516,643
551,501
539,387
519,677
476,092
548,680
572,028
589,873
563,634
563,634589,873572,028548,680476,092519,677539,387551,501516,643567,259520,012441,921399,022425,553470,976453,0320000
   Common Stock
3,000
3,364
3,364
3,364
0
0
0
0
0
3,241
0
0
3,241
0
0
0
0
0
0
0
00000003,241003,241000003,3643,3643,3643,000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 0000000-400-800000-3-3-3-3



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue763,749
Cost of Revenue-285,403
Gross Profit478,346478,346
 
Operating Income (+$)
Gross Profit478,346
Operating Expense-584,204
Operating Income179,545-105,858
 
Operating Expense (+$)
Research Development0
Selling General Administrative39,425
Selling And Marketing Expenses0
Operating Expense584,20439,425
 
Net Interest Income (+$)
Interest Income26
Interest Expense-1,988
Other Finance Cost-129
Net Interest Income-2,091
 
Pretax Income (+$)
Operating Income179,545
Net Interest Income-2,091
Other Non-Operating Income Expenses0
Income Before Tax (EBT)177,690179,545
EBIT - interestExpense = -1,988
136,881
138,869
Interest Expense1,988
Earnings Before Interest and Taxes (EBIT)0179,678
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax177,690
Tax Provision-40,814
Net Income From Continuing Ops136,876136,876
Net Income136,881
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,091
 

Technical Analysis of Laboratorios Farmaceuticos Rovi S.A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Laboratorios Farmaceuticos Rovi S.A. The general trend of Laboratorios Farmaceuticos Rovi S.A is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Laboratorios Farmaceuticos Rovi S.A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Laboratorios Farmaceuticos Rovi S.A Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Laboratorios Farmaceuticos Rovi S.A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 64.85 < 65.46 < 69.87.

The bearish price targets are: 56.90 > 51.65 > 50.64.

Know someone who trades $41L? Share this with them.👇

Laboratorios Farmaceuticos Rovi S.A Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Laboratorios Farmaceuticos Rovi S.A. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Laboratorios Farmaceuticos Rovi S.A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Moving Average Convergence/Divergence (MACD) ChartLaboratorios Farmaceuticos Rovi S.A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Laboratorios Farmaceuticos Rovi S.A. The current adx is .

Laboratorios Farmaceuticos Rovi S.A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Relative Strength Index (RSI) ChartLaboratorios Farmaceuticos Rovi S.A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Stochastic Oscillator ChartLaboratorios Farmaceuticos Rovi S.A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Commodity Channel Index (CCI) ChartLaboratorios Farmaceuticos Rovi S.A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Chande Momentum Oscillator (CMO) ChartLaboratorios Farmaceuticos Rovi S.A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Williams %R ChartLaboratorios Farmaceuticos Rovi S.A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Average True Range (ATR) ChartLaboratorios Farmaceuticos Rovi S.A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily On-Balance Volume (OBV) ChartLaboratorios Farmaceuticos Rovi S.A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Money Flow Index (MFI) ChartLaboratorios Farmaceuticos Rovi S.A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Laboratorios Farmaceuticos Rovi S.A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-08-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-09-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Laboratorios Farmaceuticos Rovi S.A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Laboratorios Farmaceuticos Rovi S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose59.700
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Laboratorios Farmaceuticos Rovi S.A with someone you think should read this too:
  • Are you bullish or bearish on Laboratorios Farmaceuticos Rovi S.A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Laboratorios Farmaceuticos Rovi S.A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Laboratorios Farmaceuticos Rovi S.A

I send you an email if I find something interesting about Laboratorios Farmaceuticos Rovi S.A.


Comments

How you think about this?

Leave a comment

Stay informed about Laboratorios Farmaceuticos Rovi S.A.

Receive notifications about Laboratorios Farmaceuticos Rovi S.A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.